HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.

Abstract
Bcl-XL is a major antiapoptotic protein in the Bcl-2 family whose overexpression is more widely observed in human lung cancer cells than that of Bcl-2, suggesting that Bcl-XL is more biologically relevant and therefore a better therapeutic target for lung cancer. Here, we screened small molecules that selectively target the BH3 domain (aa 90-98) binding pocket of Bcl-XL using the UCSF DOCK 6.1 program suite and the NCI chemical library database. We identified two new Bcl-XL inhibitors (BXI-61 and BXI-72) that exhibit selective toxicity against lung cancer cells compared with normal human bronchial epithelial cells. Fluorescence polarization assay reveals that BXI-61 and BXI-72 preferentially bind to Bcl-XL protein but not Bcl2, Bcl-w, Bfl-1/A1, or Mcl-1 in vitro with high binding affinities. Treatment of cells with BXI-72 results in disruption of Bcl-XL/Bak or Bcl-XL/Bax interaction, oligomerization of Bak, and cytochrome c release from mitochondria. Importantly, BXI-61 and BXI-72 exhibit more potent efficacy against human lung cancer than ABT-737 but less degree in platelet reduction in vivo. BXI-72 overcomes acquired radioresistance of lung cancer. On the basis of our findings, the development of BXI(s) as a new class of anticancer agents is warranted and represents a novel strategy for improving lung cancer outcome.
AuthorsDongkyoo Park, Andrew T Magis, Rui Li, Taofeek K Owonikoko, Gabriel L Sica, Shi-Yong Sun, Suresh S Ramalingam, Fadlo R Khuri, Walter J Curran, Xingming Deng
JournalCancer research (Cancer Res) Vol. 73 Issue 17 Pg. 5485-96 (Sep 01 2013) ISSN: 1538-7445 [Electronic] United States
PMID23824742 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • ABT-737
  • Acridines
  • Aminopyridines
  • BAK1 protein, human
  • BXI-61
  • BXI-72
  • Benzimidazoles
  • Biphenyl Compounds
  • Nitrophenols
  • Piperazines
  • Proto-Oncogene Proteins c-bcl-2
  • Small Molecule Libraries
  • Sulfonamides
  • bcl-2 Homologous Antagonist-Killer Protein
  • bcl-X Protein
  • Cytochromes c
Topics
  • Acridines (pharmacology)
  • Aminopyridines (pharmacology)
  • Animals
  • Apoptosis (drug effects, radiation effects)
  • Benzimidazoles (pharmacology)
  • Biphenyl Compounds (pharmacology)
  • Blotting, Western
  • Cell Proliferation (drug effects, radiation effects)
  • Cytochromes c (metabolism)
  • Female
  • Humans
  • Lung (cytology, drug effects)
  • Lung Neoplasms (drug therapy, mortality, pathology)
  • Mice
  • Mice, Nude
  • Nitrophenols (pharmacology)
  • Piperazines (pharmacology)
  • Protein Multimerization
  • Proto-Oncogene Proteins c-bcl-2 (antagonists & inhibitors, metabolism)
  • Radiation Tolerance (drug effects)
  • Radiation, Ionizing
  • Small Molecule Libraries
  • Sulfonamides (pharmacology)
  • Survival Rate
  • bcl-2 Homologous Antagonist-Killer Protein (antagonists & inhibitors, metabolism)
  • bcl-X Protein (antagonists & inhibitors, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: